Kidney Stone Management Market Reaches New Heights: Technological Innovations Define 2024-2030 Landscape

Revolutionary Technologies Drive Unprecedented Growth in Kidney Stone Treatment Solutions

The global Kidney Stone Management Market is poised for steady growth, with its market size anticipated to reach USD 3.13 billion by the end of 2025. According to projections by Next Move Strategy Consulting, the industry is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030, ultimately surpassing USD 4.13 billion by 2030. This robust growth trajectory reflects the increasing prevalence of kidney stones worldwide and the continuous advancement of treatment technologies.

Latest Market Developments Shape Treatment Standards

Cook Medical has announced a strategic collaboration with Mendaer Inc., a Silicon Valley-based healthcare technology firm, aimed at developing innovative solutions for needle-based interventions in urological procedures. The partnership will integrate Cook’s industry-leading needles with Mendaera’s advanced handheld robotic platform, marking a significant step toward enhancing precision in percutaneous procedures. Cook Medical stated that the collaboration opens new avenues for improving outcomes in minimally invasive urologic care.

The year 2024 has marked a pivotal moment for kidney stone management technology. In April 2024, Cook Medical debuted the new Ascend single-use flexible ureteroscope in the United States and Canada, representing a significant advancement in minimally invasive treatment options. This launch demonstrates the industry's commitment to providing urologists with enhanced tools for precision stone removal procedures.

Building on this momentum, in May 2025, a AIIMS Bhopal launched 3D printing to revolutionize kidney stone surgeries, enabling more precise treatment planning and execution. The University has received a ₹9 lakh grant to introduce 3D printed, patient-specific kidney models and puncture guides for Percutaneous Nephrolithotomy. Led by Dr. Mehra and Dr. Vatti, the project — supported by ₹7 lakh for advanced printing equipment and ₹2 lakh for research fellows — aims to reduce complications, shorten surgery time, and enhance precision in kidney stone treatment.

Comprehensive Application Portfolio Drives Market Expansion

The kidney stone management market encompasses various treatment modalities tailored to different patient needs and stone characteristics. By treatment type, the kidney stone management market is categorized into non-invasive treatments, minimally invasive treatments, surgical treatments, and medical management. Among these, non-invasive treatments are projected to lead the market, largely fueled by the growing popularity of Ureteroscopy (URS), which continues to dominate the minimally invasive segment and is expected to secure a substantial market share.

Minimally invasive procedures have gained significant traction among healthcare providers and patients alike. The adoption of flexible ureteroscopy has increased substantially, offering patients reduced recovery times and improved outcomes. Single-use ureteroscopes, like Cook Medical's Ascend system, address infection control concerns while maintaining high-performance standards for stone removal procedures.

The market's segment structure includes product types, stone types, technological integration, diagnostics method, treatment type, patient demographics, and end-users. Advanced technologies like AI-integrated imaging, robotic surgery, and other specialized tools form the core of modern kidney stone management solutions. These technologies work synergistically to provide comprehensive treatment pathways for patients with varying stone complexities.

Regional Market Dynamics Reveal Clear Leadership Patterns

North America Maintains Dominant Position

North America leads the global kidney stone management market, driven by a high prevalence of kidney stones. Kidney stone prevalence in the U.S. is approximately 11% among men and 7% among women. Favorable reimbursement policies, such as Medicare covering 80% of lithotripsy costs, and high patient awareness bolster demand. Innovations like Boston Scientific’s LithoVue Elite, introduced in 2023 with real-time intrarenal pressure monitoring during ureteroscopy, enhance safety and advance urological technologies, further solidifying the region’s dominance.

Europe Shows Steady Growth Trajectory

Europe is a significant market, with countries like Germany, the U.K., and France leading due to a kidney stone prevalence of 5-9%. Robust healthcare systems and increasing adoption of advanced technologies, such as laser lithotripsy and robotic-assisted surgeries, drive market growth.

Asia-Pacific Emerges as Fastest-Growing Region

Asia-Pacific is experiencing rapid market growth, fuelled by a high prevalence of kidney stones in countries like India, driven by poor dietary habits, tropical climates, and obesity. Uric acid stone cases are common in India and Pakistan, particularly in urban areas. Improving healthcare infrastructure, rising disposable incomes, and government initiatives like India’s Ayushman Bharat scheme enhance access to urological care.

Rest of the World (RoW) Shows Emerging Potential

The Rest of the World, comprising Latin America, the Middle East, and Africa, represents emerging markets, with Brazil, Mexico, Saudi Arabia, UAE, and South Africa as key contributors. Kidney stone prevalence is 10.5% in Latin America and up to 8.17% in Saudi Arabia, per the 2023 ISN Atlas. In Latin America, high proportions of chronic kidney disease-related deaths are noted in Mexico (9.8%), El Salvador (10.2%), and Nicaragua (11.9%). In the Middle East, investments like Saudi Vision 2030 and a 10% increase in UAE’s robotic-assisted surgeries in 2024 drive growth. South Africa benefits from affordable lithotripters from companies like Richard Wolf GmbH. Challenges include economic instability in Latin America, limited access in low-income African countries, and a shortage of specialists.

Strategic Moves by Key Market Players

Leading Companies Drive Innovation

Cook Medical has emerged as a key innovator in 2024 with strategic product launches. The company's introduction of the Ascen Single-Use Flexible Ureteroscope in the United States and Canada represents a significant strategic move to capture market share in the single-use device segment. The Ascend scope works with endoscopic accessories such as laser fibers, stone extractors, biopsy forceps, and the Endoscopic Video Image Processor for endoscopy and endoscopic surgery within the urinary tract and interior of the ureter and kidney.

Industry consolidation continues as major players engage in mergers and acquisitions. Cook Medical, Richard Wolf, Boston Scientific, and Dornier MedTech are actively engaged in M&As to increase market share, indicating a competitive landscape focused on expanding technological capabilities and market reach:

• Complejo Hospitalario de Mérida in Spain has upgraded its extracorporeal lithotripsy equipment, investing over €400,000 in a Dornier Delta III compact workstation to treat kidney stones non invasively. This advanced system combines superior imaging, an ergonomic treatment table, and a precise electromagnetic shock‐wave emitter with deeper penetration—enabling comfortable, supine patient positioning throughout therapy, reducing treatment time, and improving safety.

• Dornier MedTech has entered into a distribution agreement with Edge Medical to launch the MP1000 Multi Port Robotic Surgery System for urological procedures in Spain and Portugal, marking the pilot phase of this collaboration. The MP1000 combines a 3D HD vision system, flexible robotic arms, and human-like instrument navigation to enable precise, minimally invasive surgeries such as radical prostatectomies.

Emerging Companies Focus on Specialized Solutions

The market also sees significant activity from emerging companies developing specialized solutions. In May, Charles Nottingham, MD, MS, performed the first ureteroscopy with the Dornier AXIS Single-Use Digital Ureteroscope at Barnes-Jewish St. Peters Hospital, showcasing how newer technologies are being integrated into clinical practice.

These emerging players often focus on niche applications or innovative approaches to existing challenges, such as improved imaging capabilities, enhanced ergonomics, or cost-effective solutions for healthcare systems with budget constraints.

Future Prospects and Market Evolution

The kidney stone management market is poised for continued expansion, driven by several key trends. Increasing prevalence of kidney stones, technological advancements in treatment options, and rising awareness about kidney health are pivotal factors influencing the market's growth.

Technological integration will continue to reshape treatment paradigms. The combination of artificial intelligence, advanced imaging, and robotics promises to deliver more precise, efficient, and patient-friendly treatment options. Single-use devices are expected to gain further traction as healthcare facilities prioritize infection control and operational efficiency.

About Next Move Strategy Consulting: 

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry's best-quality, syndicated, as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre-consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more information, please contact:

Next Move Strategy Consulting 

5th Floor 867

Boylston St, STE 500,

Boston, MA 02116, U.S.

E-Mail: [email protected] 

Direct: +1-217-650-7991 

Website: www.nextmsc.com